General Information of the Compound
Compound ID
CP0864126
Compound Name
(3aR,9bS)-2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-one hydrochloride
    Show/Hide
Structure
Formula
C11H13ClN2O
Molecular Weight
224.691
Canonical SMILES
Cl.O=C1N[C@H]2CNC[C@@H]2c2ccccc21
    Show/Hide
InChI
InChI=1S/C11H12N2O.ClH/c14-11-8-4-2-1-3-7(8)9-5-12-6-10(9)13-11;/h1-4,9-10,12H,5-6H2,(H,13,14);1H/t9-,10+;/m1./s1
    Show/Hide
InChIKey
QEYATYWUPMRWQP-UXQCFNEQSA-N
Physicochemical Property
logP
0.9072
Rotatable Bonds
0
Heavy Atom Count
15
Polar Areas
41.13
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
15

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11492299
SID: 16594157
ChEMBL ID
CHEMBL2337495
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
2
Ki = 7957 nM
   TI
   LI
   LO
   TS
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
2
Ki = 5812 nM
   TI
   LI
   LO
   TS
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 43 nM
   TI
   LI
   LO
   TS
2
Ki = 1062 nM
   TI
   LI
   LO
   TS